Regeneron Pharmaceuticals (REGN)
Create an Alert
232.71
-4.22 -1.78%
NASDAQ
Jun 17, 8:00PM
BATS Real time
Currency in USD
Regeneron Pharmaceuticals Return on Assets:
47.45% for March 31, 2013Regeneron Pharmaceuticals Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 47.45% |
| Dec. 31, 2012 | 47.65% |
| Sept. 30, 2012 | 16.71% |
| June 30, 2012 | -2.22% |
| March 31, 2012 | -14.42% |
| Dec. 31, 2011 | -20.10% |
| Sept. 30, 2011 | -17.81% |
| June 30, 2011 | -15.62% |
| March 31, 2011 | -12.53% |
| Dec. 31, 2010 | -12.01% |
| Sept. 30, 2010 | -15.78% |
| June 30, 2010 | -12.29% |
| March 31, 2010 | -11.23% |
| Dec. 31, 2009 | -9.34% |
| Sept. 30, 2009 | -7.98% |
| June 30, 2009 | -10.38% |
| March 31, 2009 | -10.36% |
| Dec. 31, 2008 | -9.30% |
| Sept. 30, 2008 | -7.83% |
| June 30, 2008 | -10.18% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
REGN Return on Assets Benchmarks
| Companies | |
|---|---|
| Vertex Pharmaceuticals | -19.76% |
| Amgen | 8.74% |
| Biogen Idec | 15.60% |
REGN Return on Assets Rankings
| Overall |
99th percentile 93 of 16770 |
| Sector |
99th percentile 14 of 1408 in Healthcare |
| Industry |
98th percentile 6 of 453 in Biotechnology |
REGN Return on Assets Range, Past 5 Years
| Minimum | -20.10% | Dec 2011 |
| Maximum | 47.65% | Dec 2012 |
| Average | -4.38% |
